A phase II trial to study Unresectable stage III or stage IV melanoma

BH-14-067
Cancer, Cancer - Melanoma
John McCann, MD

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Baystate Franklin Medical Center
164 High Street
Greenfield, MA

The purpose of this study is to compare overall survival for patients receiving ipilimumab plus bevacizumab versus ipilimumab alone.
Unresectable Stage III or Stage IV Melanoma; untreated or one previous treatment.
Betsy Lopez
413-794-4154